Handheld Ultrasound Developer Exo Raised $220M In Series C
As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date.
You may also be interested in...
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.
GE Healthcare has announced the launch of Vscan Air, its first wireless ultrasound device.
Omdia expects revenue for ultrasound systems to contract by 8.4% in 2020, but to pick up again in 2021.